November 2017 | Volume 2

FDA (as expected) did not identify specific methods to directly mark a device. According to the agency, "it would be difficult to account for the wide variety of existing devices, use conditions and reprocessing methods." 

Mayo Clinic is collaborating on this hip and knee implant surface coating project, titled "EZH2 inhibitors as endoprosthetic device coatings that induce osteogenesis and promote implant osseointegration." 

Claris Healthcare, Consensus Orthopedics and J&J Health and Wellness Solutions each launched new offerings in an effort to help hospitals and surgeons improve patient outcomes and control spend.

We spoke with Mr. Diaz, an ORTHOWORLD Member, on several topics ranging from data collection to struggles for startups and the future of orthopaedic technology.

125 companies confirmed to date.

Advance Program Materials are due January 19. Confirm your booth and your ad reservation today!

DTM already markets the mobile-bearing Hintermann Series H3 total ankle in over 30 countries ex-U.S., where the product has a reported 17 years of established clinical efficacy. 

The handheld platform supports implant alignment and ligament balance, and offers robotics-assisted bone preparation, removing bone identified by the surgeon's patient-specific plan.


Planning goes a long way in moving from premarket to postmarket data collection. Vicki Anastasi, a past OMTEC speaker, suggests the best way to start.
Dr. Williams is a shoulder specialist at the Rothman Institute in Philadelphia who also serves as the John M. Fenlin Jr., M.D. Professor of Shoulder and Elbow Surgery at The Sidney Kimmel Medical College at Thomas Jefferson University.